| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in decreased expression of CFLAR mRNA" | 26377693 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | "15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of CFLAR protein" | 15498850 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 15905586 |
| C477931 | 1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate | 1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate results in decreased expression of CFLAR protein | 12970779 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CFLAR mRNA" | 27589474 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CFLAR mRNA" | 27291303 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CFLAR mRNA" | 19114083 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of CFLAR mRNA" | 21346803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein | 12970779|2117323 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of CFLAR protein alternative form | 16434995 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of CFLAR protein" | 18444175 |
| C557882 | 25-methoxyldammarane-3,12,20-triol | "25-methoxyldammarane-3,12,20-triol affects the expression of CFLAR protein modified form" | 21924252 |
| C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of CFLAR mRNA | 16788091 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile results in decreased expression of CFLAR mRNA | 16174796|1638044 |
| C434003 | 3-(4-methylphenylsulfonyl)-2-propenenitrile | 3-(4-methylphenylsulfonyl)-2-propenenitrile results in decreased expression of CFLAR protein | 16173963 |
| C524042 | 3,5-bis(2-fluorobenzylidene)piperidin-4-one | "3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA]" | 23452621 |
| C017906 | 3-dinitrobenzene | 3-dinitrobenzene results in increased expression of CFLAR mRNA | 22841810 |
| C554680 | 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide | 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide results in decreased expression of CFLAR mRNA | 20446019 |
| C554680 | 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide | 4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide results in decreased expression of CFLAR protein | 20446019 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of CFLAR mRNA" | 18648102 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| C580598 | 5-OH-BDE-47 | 5-OH-BDE-47 results in decreased expression of CFLAR mRNA | 27589474 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| C496492 | abrine | abrine results in increased expression of CFLAR mRNA | 22595364 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CFLAR mRNA | 21420995|2776149 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CFLAR mRNA | 17562736 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [gingerol results in decreased expression of CFLAR protein] | 25034532 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] | 25619640 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of CFLAR mRNA | 28959563 |
| D000241 | Adenosine | Adenosine results in decreased expression of CFLAR mRNA | 17303086 |
| D000241 | Adenosine | Adenosine results in decreased expression of CFLAR mRNA alternative form | 17303086 |
| D000241 | Adenosine | Adenosine results in decreased expression of CFLAR protein | 17303086 |
| D000241 | Adenosine | Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA] | 17303086 |
| D000241 | Adenosine | Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA alternative form] | 17303086 |
| D000241 | Adenosine | Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR protein] | 17303086 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased methylation of CFLAR gene | 28458013 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CFLAR mRNA | 19770486 |
| D000395 | Air Pollutants, Occupational | "Air Pollutants, Occupational results in increased expression of CFLAR mRNA" | 19936710 |
| C077990 | alvocidib | alvocidib affects the expression of CFLAR mRNA | 16951203 |
| C077990 | alvocidib | alvocidib results in decreased expression of CFLAR | 16820931 |
| C077990 | alvocidib | alvocidib results in decreased expression of CFLAR protein | 16951203 |
| C077990 | alvocidib | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [alvocidib results in decreased expression of CFLAR protein] | 16951203 |
| D000638 | Amiodarone | Amiodarone results in decreased expression of CFLAR protein | 21224497 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CFLAR mRNA | 16483693 |
| C088115 | anacardic acid | anacardic acid inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 18349320 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of CFLAR mRNA | 17696278 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of CFLAR mRNA | 24449571 |
| C000228 | aristolochic acid I | [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CFLAR mRNA | 23912714 |
| C042310 | aristolochic acid II | [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of CFLAR mRNA | 23912714 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein | 17673311 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of CFLAR protein] | 23082001 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CFLAR mRNA | 16174796 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CFLAR protein | 16105982|1617479 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of CFLAR protein alternative form | 16434995 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CFLAR mRNA | 22521957 |
| C006632 | arsenic trioxide | BCL2 inhibits the reaction [[arsenic trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein] | 17673311 |
| C006632 | arsenic trioxide | CFLAR protein results in decreased susceptibility to arsenic trioxide | 16105982 |
| D001241 | Aspirin | Aspirin results in increased expression of CFLAR mRNA | 20457246 |
| D001241 | Aspirin | Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| D001397 | Azoxymethane | Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| D001397 | Azoxymethane | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein | 25449198 |
| D001397 | Azoxymethane | Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| D001397 | Azoxymethane | Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| C006680 | baicalein | baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] | 20850421 |
| C012765 | bakuchiol | bakuchiol results in decreased expression of CFLAR protein | 27033605 |
| C004456 | beauvericin | beauvericin results in increased expression of CFLAR mRNA | 29203277 |
| D001564 | Benzo(a)pyrene | AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of CFLAR mRNA] | 15034205 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of CFLAR mRNA | 15034205 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde affects the expression of CFLAR protein alternative form | 17510429 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [alvocidib results in decreased expression of CFLAR protein] | 16951203 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [(+)-JQ1 compound results in decreased expression of CFLAR protein] | 26415225 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Quercetin results in decreased expression of CFLAR protein alternative form] | 18980244 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [shogaol results in decreased expression of CFLAR protein modified form] | 25619640 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] affects the localization of CFLAR protein] | 19643600 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein] | 19643600 |
| D019207 | beta Carotene | beta Carotene results in increased expression of CFLAR mRNA | 17034753 |
| D004958 | Estradiol | Estradiol affects the expression of CFLAR mRNA | 21826169 |
| C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A affects the expression of CFLAR mRNA | 21786754 |
| C006780 | bisphenol A | bisphenol A affects the expression of CFLAR mRNA | 21826169 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CFLAR mRNA | 20678512|2927551 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CFLAR mRNA | 22687993 |
| C006780 | bisphenol A | bisphenol A affects the expression of CFLAR mRNA | 25181051 |
| D000069286 | Bortezomib | Bortezomib affects the expression of CFLAR protein | 17326159 |
| D000069286 | Bortezomib | [Bortezomib co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein | 19100720|2051594 |
| D000069286 | Bortezomib | Bortezomib results in decreased expression of CFLAR mRNA | 17659339 |
| D000069286 | Bortezomib | Bortezomib results in decreased expression of CFLAR protein | 17327374|1765933 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of CFLAR protein | 19100720|2087677 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of CFLAR protein alternative form | 17510429 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of CFLAR protein modified form | 17351739 |
| D000069286 | Bortezomib | CFLAR protein alternative form results in decreased susceptibility to Bortezomib | 17510429 |
| D000069286 | Bortezomib | CFLAR results in decreased susceptibility to Bortezomib | 17510429 |
| D000069286 | Bortezomib | [romidepsin co-treated with Bortezomib] results in decreased expression of CFLAR protein | 18223231 |
| D000069286 | Bortezomib | TNFSF10 protein promotes the reaction [Bortezomib results in decreased expression of CFLAR protein] | 17659339 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form | 16709600 |
| C018475 | butyraldehyde | butyraldehyde results in decreased expression of CFLAR mRNA | 26079696 |
| D002087 | Butyrates | Butyrates results in decreased expression of CFLAR mRNA | 16042588 |
| C584509 | C646 compound | C646 compound results in increased expression of CFLAR mRNA | 26191083 |
| C584509 | C646 compound | C646 compound results in increased expression of CFLAR mRNA | 26921506 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CFLAR mRNA | 19010381 |
| C053400 | cafestol | cafestol results in decreased expression of CFLAR protein | 21334318 |
| D002166 | Camptothecin | Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| D002211 | Capsaicin | Capsaicin results in decreased expression of CFLAR protein alternative form | 19939880 |
| D002211 | Capsaicin | Capsaicin results in increased expression of CFLAR mRNA | 19502594 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of CFLAR mRNA | 24752500 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CFLAR mRNA | 17484886 |
| C038590 | cardanol | cardanol results in decreased expression of CFLAR mRNA | 26694491 |
| D000068579 | Celecoxib | Celecoxib results in decreased expression of CFLAR | 17145853 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene | 20938992 |
| D002922 | Ciguatoxins | Ciguatoxins affects the expression of CFLAR mRNA | 18353800 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of CFLAR mRNA | 23811191 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of CFLAR mRNA | 25125499 |
| C018021 | cobaltous chloride | lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in decreased expression of CFLAR mRNA] | 25125499 |
| D003042 | Cocaine | Cocaine affects the expression of CFLAR mRNA | 15681117 |
| D003375 | Coumestrol | Coumestrol results in decreased expression of CFLAR mRNA | 19167446 |
| D003471 | Cuprizone | Cuprizone results in decreased expression of CFLAR mRNA | 26577399 |
| D003471 | Cuprizone | Cuprizone results in increased expression of CFLAR mRNA | 27523638 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] | 23452621 |
| D003474 | Curcumin | Curcumin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA] | 16219905 |
| D003474 | Curcumin | Curcumin results in decreased expression of CFLAR protein | 16173963 |
| D003513 | Cycloheximide | Cycloheximide results in decreased expression of CFLAR protein | 12663669|1607719 |
| D003513 | Cycloheximide | Cycloheximide results in decreased expression of CFLAR protein alternative form | 15924153 |
| D003513 | Cycloheximide | Cycloheximide results in decreased expression of CFLAR protein modified form | 25619640 |
| D003513 | Cycloheximide | shogaol promotes the reaction [Cycloheximide results in decreased expression of CFLAR protein modified form] | 25619640 |
| D003609 | Dactinomycin | Dactinomycin results in decreased expression of CFLAR protein | 11234897|1460105 |
| C014347 | decitabine | decitabine affects the expression of CFLAR protein | 18636160 |
| C107676 | deguelin | deguelin inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA] | 22623043 |
| C107676 | deguelin | deguelin results in decreased expression of CFLAR mRNA | 22623043 |
| C464444 | dehydroxymethylepoxyquinomicin | [dehydroxymethylepoxyquinomicin co-treated with TNF protein] results in decreased expression of CFLAR | 16211219 |
| D003703 | Demecolcine | Demecolcine results in increased expression of CFLAR mRNA | 23649840 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of CFLAR | 21244764 |
| D003907 | Dexamethasone | Dexamethasone results in increased expression of CFLAR mRNA | 25047013 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA | 28628672 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR] | 21244764 |
| D016264 | Dextran Sulfate | Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| D016264 | Dextran Sulfate | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein | 25449198 |
| D016264 | Dextran Sulfate | Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| D016264 | Dextran Sulfate | Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in decreased expression of CFLAR protein | 25205294 |
| D003976 | Diazinon | Diazinon results in increased expression of CFLAR mRNA | 27920530 |
| D003976 | Diazinon | Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] | 27920530 |
| D003976 | Diazinon | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] | 27920530 |
| D003976 | Diazinon | Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA] | 27920530 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of CFLAR protein | 14601052|2087677 |
| D002945 | Cisplatin | [Cisplatin results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein | 20876774 |
| D002945 | Cisplatin | CFLAR protein results in decreased susceptibility to Cisplatin | 20683665 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of CFLAR | 21877938 |
| D004008 | Diclofenac | Diclofenac affects the expression of CFLAR mRNA | 24752500 |
| D004008 | Diclofenac | [Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein | 20237495 |
| D004051 | Diethylhexyl Phthalate | Diethylhexyl Phthalate results in decreased expression of CFLAR mRNA | 19850644 |
| D004051 | Diethylhexyl Phthalate | PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of CFLAR mRNA] | 19850644 |
| C014476 | diethyl maleate | diethyl maleate results in decreased expression of CFLAR mRNA | 21161181 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of CFLAR mRNA" | 21294050 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CFLAR mRNA]" | 21294050 |
| D004121 | Dimethyl Sulfoxide | Dimethyl Sulfoxide affects the expression of CFLAR mRNA | 24834073 |
| D004144 | Diosgenin | Diosgenin inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 16331273 |
| D004144 | Diosgenin | Diosgenin results in decreased expression of CFLAR protein | 16331273 |
| D004176 | Dipyridamole | Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA] | 17303086 |
| D004176 | Dipyridamole | Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR mRNA alternative form] | 17303086 |
| D004176 | Dipyridamole | Dipyridamole inhibits the reaction [Adenosine results in decreased expression of CFLAR protein] | 17303086 |
| D004237 | Diuron | Diuron results in increased expression of CFLAR mRNA | 25152437 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of CFLAR protein | 14601052|1589791 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of CFLAR protein | 15703961 |
| C118739 | entinostat | entinostat results in decreased expression of CFLAR mRNA | 26272509|2718838 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CFLAR mRNA | 22079256 |
| C078846 | epoxomicin | epoxomicin affects the expression of CFLAR protein alternative form | 17510429 |
| D004976 | Ethacrynic Acid | arsenic trioxide promotes the reaction [Ethacrynic Acid results in decreased expression of CFLAR protein] | 23082001 |
| D004976 | Ethacrynic Acid | Ethacrynic Acid results in decreased expression of CFLAR protein | 23082001 |
| D000431 | Ethanol | Ethanol results in increased expression of CFLAR protein | 19429258 |
| D005020 | Ethyl Methanesulfonate | Ethyl Methanesulfonate results in increased expression of CFLAR mRNA | 23649840 |
| D005047 | Etoposide | Etoposide results in increased expression of CFLAR protein | 14601052 |
| C049639 | evodiamine | evodiamine inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 15710601 |
| D005472 | Fluorouracil | CFLAR protein affects the susceptibility to Fluorouracil | 15548681|1621774 |
| D005472 | Fluorouracil | CFLAR protein alternative form inhibits the reaction [Fluorouracil results in increased activity of TNFSF10 protein] | 16373718 |
| D005472 | Fluorouracil | CFLAR protein inhibits the reaction [Fluorouracil results in increased susceptibility to TNFSF10 protein] | 20876774 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with IFNA1 protein] results in decreased expression of CFLAR protein | 17045692 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of CFLAR mRNA | 17045692|2087677 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of CFLAR protein | 16373718|1704569 |
| D005472 | Fluorouracil | [Fluorouracil results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein | 20876774 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of CFLAR mRNA | 15152939 |
| D005472 | Fluorouracil | IFNA1 protein promotes the reaction [Fluorouracil results in decreased expression of CFLAR mRNA] | 17045692 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene | 20938992 |
| D005557 | Formaldehyde | Formaldehyde results in increased expression of CFLAR mRNA | 23649840 |
| D005688 | Galactosamine | baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] | 20850421 |
| D005688 | Galactosamine | [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein | 20850421 |
| D005688 | Galactosamine | Silymarin inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] | 20850421 |
| D019833 | Genistein | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] | 23452621 |
| C007845 | gingerol | Acetylcysteine inhibits the reaction [gingerol results in decreased expression of CFLAR protein] | 25034532 |
| C007845 | gingerol | gingerol results in decreased expression of CFLAR protein | 25034532 |
| D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid results in decreased expression of and results in increased phosphorylation of CFLAR protein | 25125499 |
| D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid promotes the reaction [lysophosphatidylethanolamine analog results in increased expression of CFLAR protein] | 25125499 |
| D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid results in increased expression of CFLAR protein | 25125499 |
| D005999 | Glycochenodeoxycholic Acid | lysophosphatidylethanolamine analog promotes the reaction [Glycochenodeoxycholic Acid results in increased expression of CFLAR protein] | 25125499 |
| C529376 | GYY 4137 | GYY 4137 results in decreased expression of CFLAR protein | 25205294 |
| D017313 | Fenretinide | Fenretinide inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 16230421 |
| D017313 | Fenretinide | Fenretinide results in decreased expression of CFLAR protein | 16230421 |
| D006820 | Hyaluronic Acid | [Diclofenac co-treated with Hyaluronic Acid] results in decreased expression of CFLAR protein | 20237495 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CFLAR protein | 18603805 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of CFLAR protein | 16157298 |
| D006886 | Hydroxychloroquine | Hydroxychloroquine results in decreased expression of CFLAR mRNA | 16734620 |
| D006886 | Hydroxychloroquine | Hydroxychloroquine results in decreased expression of CFLAR protein | 16734620 |
| C492448 | ICG 001 | ICG 001 results in increased expression of CFLAR mRNA | 26191083 |
| D000068877 | Imatinib Mesylate | [tetraarsenic tetrasulfide co-treated with Imatinib Mesylate] results in decreased expression of CFLAR mRNA | 19208803 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 15811958 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in decreased expression of CFLAR | 16082211 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [LTA protein results in increased expression of CFLAR protein] | 17873517 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA | 28628672 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of CFLAR mRNA | 25972201 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CFLAR mRNA | 25613284 |
| C051890 | irinotecan | CFLAR protein affects the susceptibility to irinotecan | 16373718 |
| C051890 | irinotecan | CFLAR protein alternative form inhibits the reaction [irinotecan results in increased activity of TNFSF10 protein] | 16373718 |
| C051890 | irinotecan | irinotecan results in decreased expression of CFLAR protein | 16373718 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CFLAR mRNA | 28628672 |
| C477508 | jaceosidin | CFLAR protein inhibits the reaction [jaceosidin results in increased cleavage of PARP1 protein] | 27729209 |
| C477508 | jaceosidin | jaceosidin results in decreased expression of CFLAR mRNA | 27729209 |
| C477508 | jaceosidin | jaceosidin results in decreased expression of CFLAR protein | 27729209 |
| C477508 | jaceosidin | RELA protein inhibits the reaction [jaceosidin results in decreased expression of CFLAR protein] | 27729209 |
| C477508 | jaceosidin | SP1 protein inhibits the reaction [jaceosidin results in decreased expression of CFLAR protein] | 27729209 |
| C561695 | (+)-JQ1 compound | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [(+)-JQ1 compound results in decreased expression of CFLAR protein] | 26415225 |
| C561695 | (+)-JQ1 compound | CFLAR protein results in decreased susceptibility to [(+)-JQ1 compound co-treated with TNFSF10 protein] | 26415225 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound analog results in decreased expression of CFLAR protein | 26415225 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CFLAR mRNA | 23086925|2479639 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of CFLAR protein | 26415225 |
| C046438 | kahweol acetate | CFLAR protein inhibits the reaction [[TNFSF10 protein co-treated with kahweol acetate] results in increased activity of CASP8 protein] | 20403343 |
| C046438 | kahweol acetate | [TNFSF10 protein co-treated with kahweol acetate] results in decreased expression of CFLAR protein | 20403343 |
| C046438 | kahweol acetate | CFLAR protein results in decreased susceptibility to [TNFSF10 protein co-treated with kahweol acetate] | 20403343 |
| C433788 | lipopolysaccharide, E. coli O26-B6 | "lipopolysaccharide, E. coli O26-B6 results in increased expression of CFLAR mRNA" | 23090859 |
| D008070 | Lipopolysaccharides | baicalein inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] | 20850421 |
| D008070 | Lipopolysaccharides | [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein | 20850421 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CFLAR mRNA | 10975854 |
| D008070 | Lipopolysaccharides | Silymarin inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] | 20850421 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of CFLAR mRNA | 21645290 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 15090542 |
| C008301 | lysophosphatidylethanolamine | lysophosphatidylethanolamine analog inhibits the reaction [cobaltous chloride results in decreased expression of CFLAR mRNA] | 25125499 |
| C008301 | lysophosphatidylethanolamine | lysophosphatidylethanolamine analog results in increased expression of CFLAR mRNA | 25125499 |
| C008301 | lysophosphatidylethanolamine | lysophosphatidylethanolamine analog results in increased expression of CFLAR protein | 25125499 |
| C008301 | lysophosphatidylethanolamine | Glycochenodeoxycholic Acid promotes the reaction [lysophosphatidylethanolamine analog results in increased expression of CFLAR protein] | 25125499 |
| C008301 | lysophosphatidylethanolamine | lysophosphatidylethanolamine analog promotes the reaction [Glycochenodeoxycholic Acid results in increased expression of CFLAR protein] | 25125499 |
| C008301 | lysophosphatidylethanolamine | lysophosphatidylethanolamine analog results in increased expression of CFLAR protein | 25125499 |
| D008277 | Magnesium Oxide | Magnesium Oxide analog inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] | 27920530 |
| D008277 | Magnesium Oxide | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] | 27920530 |
| D058185 | Magnetite Nanoparticles | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CFLAR mRNA | 26378955 |
| D058185 | Magnetite Nanoparticles | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CFLAR mRNA | 21641980 |
| D017258 | Medroxyprogesterone Acetate | [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form | 16709600 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CFLAR gene | 20938992 |
| D008727 | Methotrexate | Methotrexate results in increased expression of CFLAR mRNA | 17696278|2167806 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of CFLAR mRNA" | 26251327 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CFLAR mRNA" | 20188158 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of CFLAR mRNA" | 15329391 |
| C008493 | methylselenic acid | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of CFLAR protein" | 18444175 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of CFLAR] | 21244764 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]] | 12645856 |
| D015735 | Mifepristone | Mifepristone results in decreased expression of CFLAR mRNA | 25972201 |
| C016599 | mono-(2-ethylhexyl)phthalate | [FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein | 20100735 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in decreased expression of CFLAR mRNA | 25177542 |
| C406082 | monomethylarsonous acid | monomethylarsonous acid results in increased expression of CFLAR mRNA | 20886546 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of CFLAR mRNA" | 25554681|2562005 |
| D009532 | Nickel | Nickel results in increased expression of CFLAR mRNA | 24768652|2558310 |
| C022838 | nickel chloride | nickel chloride affects the expression of CFLAR mRNA | 22546817 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of CFLAR mRNA | 16780908 |
| C558013 | NSC 689534 | NSC 689534 results in increased expression of CFLAR mRNA | 20971185 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of CFLAR mRNA | 18417182 |
| C016340 | o,p'-DDT | "o,p'-DDT analog results in decreased expression of CFLAR mRNA" | 22937105 |
| D008939 | Mitotane | Mitotane analog results in increased expression of CFLAR mRNA | 23485034 |
| C030110 | oxaliplatin | CFLAR protein affects the susceptibility to oxaliplatin | 16373718 |
| C030110 | oxaliplatin | CFLAR protein alternative form inhibits the reaction [oxaliplatin results in increased activity of TNFSF10 protein] | 16373718 |
| C030110 | oxaliplatin | oxaliplatin results in decreased expression of CFLAR protein | 16373718 |
| D010100 | Oxygen | "3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA]" | 23452621 |
| D010100 | Oxygen | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] | 23452621 |
| D010100 | Oxygen | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] | 23452621 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of CFLAR mRNA | 23452621 |
| D010100 | Oxygen | Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] | 23452621 |
| D010100 | Oxygen | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] | 23452621 |
| D017239 | Paclitaxel | CFLAR protein results in decreased susceptibility to Paclitaxel | 16080463 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| C551803 | PCI 32765 | PCI 32765 results in decreased expression of CFLAR mRNA | 26254443 |
| D000068437 | Pemetrexed | CFLAR results in decreased susceptibility to Pemetrexed | 21726997 |
| C046012 | pentanal | pentanal results in decreased expression of CFLAR mRNA | 26079696 |
| D010431 | Pentoxifylline | [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein | 20804743 |
| D010431 | Pentoxifylline | Pentoxifylline results in decreased expression of CFLAR protein | 18851957 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in decreased expression of CFLAR mRNA | 25868421 |
| C539933 | pevonedistat | pevonedistat affects the expression of CFLAR mRNA | 24634471 |
| C526145 | Phellinus linteus extract | Phellinus linteus extract results in decreased expression of CFLAR protein alternative form | 16868541 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of CFLAR mRNA | 19159669 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of CFLAR mRNA | 23091169 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of CFLAR mRNA | 18445702|2381119 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] | 23452621 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of CFLAR protein | 25449198 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] | 25449198 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CFLAR mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of CFLAR mRNA | 22079256 |
| C023617 | pregna-4,17-diene-3,16-dione | "pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased expression of CFLAR mRNA]" | 15322087 |
| D011374 | Progesterone | Progesterone results in increased expression of CFLAR mRNA | 21770760 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of CFLAR mRNA | 24780913 |
| D047428 | Protein Kinase Inhibitors | Protein Kinase Inhibitors results in decreased expression of CFLAR protein | 21173233 |
| D011794 | Quercetin | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Quercetin results in decreased expression of CFLAR protein alternative form] | 18980244 |
| D011794 | Quercetin | Quercetin results in decreased expression of CFLAR mRNA | 23727915 |
| D011794 | Quercetin | Quercetin results in decreased expression of CFLAR protein alternative form | 18980244 |
| D011794 | Quercetin | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of CFLAR mRNA]" | 21294050 |
| C059514 | resveratrol | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of CFLAR protein" | 18444175 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of CFLAR mRNA] | 23452621 |
| C059514 | resveratrol | resveratrol results in decreased cleavage of CFLAR protein | 18222423 |
| C059514 | resveratrol | resveratrol results in decreased expression of CFLAR protein | 20097879 |
| C059514 | resveratrol | TNFSF10 protein promotes the reaction [resveratrol results in decreased expression of CFLAR protein] | 20097879 |
| C059514 | resveratrol | resveratrol results in decreased expression of CFLAR protein | 17872969 |
| C059514 | resveratrol | resveratrol results in increased expression of CFLAR mRNA | 16081268 |
| C059514 | resveratrol | resveratrol results in decreased expression of CFLAR protein | 18454317 |
| D012293 | Rifampin | Mifepristone inhibits the reaction [Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form]] | 12645856 |
| D012293 | Rifampin | Rifampin inhibits the reaction [FAS protein results in increased expression of CFLAR protein modified form] | 12645856 |
| D012293 | Rifampin | Rifampin results in increased expression of CFLAR protein | 11958592 |
| C087123 | romidepsin | [romidepsin co-treated with Bortezomib] results in decreased expression of CFLAR protein | 18223231 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of CFLAR mRNA | 19467017|1973182 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of CFLAR protein | 18164688 |
| C089730 | rosiglitazone | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] | 19467017|1973182 |
| C046245 | rubimaillin | BCL2L1 protein inhibits the reaction [rubimaillin results in increased cleavage of CFLAR protein] | 19716835 |
| C046245 | rubimaillin | rubimaillin results in increased cleavage of CFLAR protein | 19716835 |
| C513635 | S-2-pentyl-4-pentynoic hydroxamic acid | S-2-pentyl-4-pentynoic hydroxamic acid results in decreased expression of CFLAR mRNA | 21427059 |
| D012524 | Sarin | Sarin results in increased expression of CFLAR mRNA | 19522546 |
| D012643 | Selenium | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in increased expression of CFLAR mRNA] | 27920530 |
| D012643 | Selenium | Selenium analog promotes the reaction [Diazinon results in increased expression of CFLAR mRNA] | 27920530 |
| C042431 | S-ethyl glutathione | S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] | 25619640 |
| C040115 | shogaol | Acetylcysteine inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] | 25619640 |
| C040115 | shogaol | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [shogaol results in decreased expression of CFLAR protein modified form] | 25619640 |
| C040115 | shogaol | CFLAR protein modified form inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]] | 25619640 |
| C040115 | shogaol | S-ethyl glutathione inhibits the reaction [shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form]] | 25619640 |
| C040115 | shogaol | shogaol promotes the reaction [Cycloheximide results in decreased expression of CFLAR protein modified form] | 25619640 |
| C040115 | shogaol | shogaol promotes the reaction [TNFSF10 protein results in decreased expression of CFLAR protein modified form] | 25619640 |
| C040115 | shogaol | shogaol results in decreased expression of CFLAR protein modified form | 25619640 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of CFLAR mRNA | 19073995 |
| D012834 | Silver | Silver results in decreased expression of CFLAR mRNA | 27131904 |
| D012838 | Silymarin | Silymarin inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CFLAR protein] | 20850421 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 17277159 |
| D019821 | Simvastatin | Simvastatin results in decreased expression of CFLAR protein | 18521906 |
| D019821 | Simvastatin | Simvastatin results in decreased expression of CFLAR protein alternative form | 21910007 |
| D019821 | Simvastatin | Simvastatin results in increased expression of CFLAR mRNA | 19262002 |
| D019821 | Simvastatin | Simvastatin results in increased expression of CFLAR protein | 19262002 |
| C118258 | SN50 peptide | SN50 peptide results in decreased expression of CFLAR protein | 12970779 |
| C009277 | sodium arsenate | sodium arsenate results in decreased expression of CFLAR mRNA | 21795629 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CFLAR mRNA | 12016162|2088654 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CFLAR mRNA | 19822182 |
| C471405 | sorafenib | [sorafenib co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein | 17909059 |
| C471405 | sorafenib | sorafenib results in decreased expression of CFLAR protein | 17909059 |
| C471405 | sorafenib | [sorafenib results in decreased expression of CFLAR protein] which results in increased susceptibility to TNFSF10 protein | 17909059 |
| C471405 | sorafenib | sorafenib results in increased degradation of CFLAR protein | 20071162 |
| C471405 | sorafenib | [sorafenib results in increased degradation of CFLAR protein] which results in increased susceptibility to TNFSF10 protein | 20071162 |
| C471405 | sorafenib | [sorafenib co-treated with vorinostat] results in decreased expression of CFLAR protein modified form | 18787411 |
| D004113 | Succimer | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CFLAR mRNA | 26378955 |
| D004113 | Succimer | [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CFLAR mRNA | 21641980 |
| C025462 | sulindac sulfide | sulindac sulfide results in decreased expression of CFLAR protein | 11912124 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein modified form | 17767197 |
| C021751 | tanshinone | tanshinone results in increased expression of CFLAR protein | 26203587 |
| C534735 | tetraarsenic tetrasulfide | [tetraarsenic tetrasulfide co-treated with Imatinib Mesylate] results in decreased expression of CFLAR mRNA | 19208803 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in decreased expression of CFLAR mRNA | 25975270 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CFLAR mRNA | 18334599 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CFLAR protein | 18334599 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CFLAR mRNA | 12167310 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CFLAR mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CFLAR mRNA | 19520675 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CFLAR mRNA | 25613284 |
| D013792 | Thalidomide | Thalidomide results in decreased expression of CFLAR protein | 15986355 |
| D013853 | Thioacetamide | Thioacetamide results in decreased expression of CFLAR mRNA | 23411599 |
| D014118 | Toxins, Biological | "Toxins, Biological affects the expression of CFLAR mRNA" | 19682533 |
| D014212 | Tretinoin | [Tretinoin co-treated with TGFB1 protein] results in increased expression of CFLAR protein | 16242776 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of CFLAR mRNA] | 19467017|1973182 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CFLAR mRNA | 21934132 |
| D014241 | Trichloroethylene | Trichloroethylene results in decreased expression of CFLAR mRNA | 19448997 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of CFLAR mRNA | 28542535 |
| C046488 | trimethyltin | trimethyltin results in increased expression of CFLAR mRNA | 21435392 |
| C057693 | troglitazone | troglitazone results in decreased expression of CFLAR protein | 16820965 |
| C057693 | troglitazone | troglitazone results in increased expression of CFLAR mRNA | 28973697 |
| D014415 | Tunicamycin | Tunicamycin results in increased expression of CFLAR mRNA | 17127020 |
| C004218 | tylophorine | tylophorine analog results in increased expression of CFLAR mRNA | 19284764 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid analog results in increased expression of CFLAR protein | 21146893 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CFLAR mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of CFLAR mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of CFLAR mRNA | 23179753|2627250 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of CFLAR mRNA | 21427059 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of CFLAR gene | 25560391 |
| C025643 | vinclozolin | vinclozolin affects the expression of CFLAR mRNA | 19015723 |
| D014750 | Vincristine | Vincristine results in increased expression of CFLAR mRNA | 23649840 |
| C029297 | vinylidene chloride | vinylidene chloride results in decreased expression of CFLAR mRNA | 26682919 |
| D014810 | Vitamin E | Vitamin E results in increased expression of CFLAR mRNA | 19244175 |
| C111237 | vorinostat | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] affects the localization of CFLAR protein] | 19643600 |
| C111237 | vorinostat | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[vorinostat co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein] | 19643600 |
| C111237 | vorinostat | [vorinostat co-treated with TNFSF10 protein] affects the localization of CFLAR protein | 19643600 |
| C111237 | vorinostat | [vorinostat co-treated with TNFSF10 protein] results in decreased expression of CFLAR protein | 19643600 |
| C111237 | vorinostat | vorinostat inhibits the reaction [TNF protein results in increased expression of CFLAR protein] | 16377638 |
| C111237 | vorinostat | vorinostat results in decreased expression of CFLAR protein | 15897598|1964360 |
| C111237 | vorinostat | vorinostat results in decreased expression of CFLAR protein modified form | 17351739 |
| C111237 | vorinostat | vorinostat results in increased expression of CFLAR protein modified form | 17351739 |
| C111237 | vorinostat | [sorafenib co-treated with vorinostat] results in decreased expression of CFLAR protein modified form | 18787411 |
| C403304 | zerumbone | zerumbone results in decreased expression of CFLAR mRNA | 16007145 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of CFLAR mRNA | 24714768 |